Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 234,191 | 243,786 | 231,344 | 225,785 | 206,733 |
| Cost of Goods | 149,140 | 154,034 | 150,312 | 152,273 | 136,750 |
| Gross Profit | 85,051 | 89,752 | 81,032 | 73,512 | 69,983 |
| Operating Expenses | 11,285 | 16,898 | 17,780 | 15,982 | 14,234 |
| Operating Income | 73,906 | 72,888 | 63,564 | 57,803 | 56,499 |
| Interest Expense | 2,190 | 2,216 | 3,825 | 2,499 | 2,360 |
| Other Income | 0 | -142 | -31 | -210 | -629 |
| Pre-tax Income | 71,716 | 70,530 | 59,708 | 55,094 | 53,510 |
| Income Tax | 17,786 | 17,371 | 14,599 | 14,710 | 7,518 |
| Net Income Continuous | 53,930 | 53,159 | 45,109 | 40,384 | 45,992 |
| Minority Interests | -21 | 83 | 242 | -67 | -298 |
| Net Income | $53,951 | $53,076 | $44,867 | $40,451 | $46,290 |
| EPS Basic Total Ops | 1.13 | 1.13 | 0.96 | 0.88 | 1.02 |
| EPS Basic Continuous Ops | 1.13 | 1.13 | 0.97 | 0.88 | 1.02 |
| EPS Diluted Total Ops | 1.13 | 1.12 | 0.93 | 0.83 | 0.94 |
| EPS Diluted Continuous Ops | 1.12 | 1.11 | 0.94 | 0.83 | 0.94 |
| EBITDA(a) | $79,789 | $78,817 | $69,302 | $63,608 | $62,330 |